TSG-6 administration significantly increased MBP and GFAP expression in BPD brain (corpus callosum and hippocampus regions, respectively) (Additional file 1: Figure S12E-H), compared to BPD or PBS-injected groups, suggesting a dcrease in myelin loss and an increase in astrocyte formation. This evidence concerns the gene MBP and bronchopulmonary dysplasia.